Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001601830-25-000045
Filing Date
2025-03-19
Accepted
2025-03-19 16:25:58
Documents
2
Period of Report
2025-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1742415952.html 3  
1 FORM 3 wk-form3_1742415952.xml 3 1578
2 EX-24.1 powerofattorney-elainesun.htm EX-24.1 4340
  Complete submission text file 0001601830-25-000045.txt   7461
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
Sun Elaine D (Reporting) CIK: 0001805339 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 25753090